Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
PhishPharm - Detail
FDA Home
PhishPharm
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Title:
Tissue distribution and residue depletion of oxolinic acid in gilthead seabream (Sparus aurata) and sharpsnout sea bream (Diplodus puntazzo) following multiple in-feed dosings.
Authors:
Rigos G, Nengas I, Alexis M, Tyrpenou AE, Troisi GM
Drug:
Oxolinic acid
Fish species:
Seabream, sharpsnout
Date:
2004
t1/2-hr:
11
Sample:
liver
Ave Weight (gm):
120
Ave Water temp (°C):
19
Water:
Saltwater
Dosage:
30 mg/kg 10 d
Route:
PO
Comments:
Displayed biphasic elimination in tissues and reached "consumer safe levels 24 h after treatment. Residues ng/mg = d1=2220, d2=1310, d3=1180, d4=2720, d5=960, d6=990, d7=990, d8=470, d9=420, d10=300, d11=60, d12=20, d14=20,d15=20,d17=20. AUC=312 ug/h ml.
Citation:
Aquaculture 224:245-256
Link:
http://dx.doi.org/10.1016/S0044-8486(03)00213-8
Genus Species:
Diplodus puntazzo
Drug Class:
Antibiotic-Quinolone
t1/2-detail:
11 h
Wt gm-detail:
120+/-20 g
Water temp (°C)-detail:
19 +/-1 C
Dosage-detail:
30 mg/kg for 10 d
Method:
HPLC
Authors-red:
Rigos G, Nengas I, Alexis M, Tyrpenou AE, Troisi GM
-
-